COCP CIK: 1412486

Cocrystal Pharma, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.7
FY22:
−21.4
FY23:
−14.7
FY24:
−16.5
FY25:
−8.19
Change from FY21 to FY25
millions USD
FY21:
−0.05
FY22:
−0.07
FY23:
−0.12
FY24:
−0.01
FY25:
−0.01
Change from FY21 to FY25
millions USD
FY21:
38.5
FY22:
−0.03
FY23:
3.99
FY24:
–
FY25:
5.37
millions USD
FY21:
25.7
FY22:
−21.5
FY23:
−10.8
FY24:
−16.5
FY25:
−2.84
(positive)
Change from FY21 to FY25
millions USD
FY21:
−12.8
FY22:
−21.5
FY23:
−14.8
FY24:
−16.5
FY25:
−8.20

All amounts in millions USD Data source:SEC EDGAR